Latest Industry Insights

We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.

In this interview, we speak to Dr. Simon Chandler, CEO of Rinri Therapeutics, to learn more about a new surgical method of accessing the human cochlea which could pave the way for new therapies for hearing loss.

This article spotlights the driving forces behind Basel’s snowballing reputation, and notes some of the success stories arising from this innovative biotech powerhouse.

In this interview, Sebastian Selzer discusses the advantages of cell culture in stirred-tank bioreactors.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

In this article, we explore how equipment, laboratory and experimental approaches can accelerate failure so companies change and adjust their approach before it’s too late.

To learn more about cell and gene therapy and some of the challenges facing the industry and the benefits that automation can bring, Technology Networks spoke with Nirupama Pike PhD, senior director of technical affairs at Thermo Fisher Scientific.

This article discusses how specialized charge detection mass spectrometers have been developed to enable simultaneous charge detection and decipher large and complex macromolecules, ultimately increasing accuracy and providing high-resolution measurements for better analysis of biotherapeutics.

Technology Networks connected with Dr. Kyle Luttgeharm, product manager at Agilent, head of his talk for the Technology Networks online symposium: Vaccine Research and Development 2022.

In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.